{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:18:17Z","timestamp":1762352297287,"version":"build-2065373602"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-19-CE15-0026"],"award-info":[{"award-number":["ANR-19-CE15-0026"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    and\n                    <jats:italic>Cryptosporidium<\/jats:italic>\n                    species are apicomplexan parasites of significant medical and veterinary importance. Although current therapeutic options for toxoplasmosis and cryptosporidiosis demonstrate notable efficacy, their clinical efficacy is often limited by suboptimal efficacy and frequent adverse effects. Moreover, therapeutic alternatives remain limited or nonexistent, particularly for cryptosporidiosis, for which nitazoxanide is currently the only approved medication to treat diarrhea in adults and children older than 1 year of age. To identify alternative therapeutic options for addressing these health challenges, we performed a phenotypic screening of an FDA-approved drug repurposing library against\n                    <jats:italic>Toxoplasma<\/jats:italic>\n                    . This screening identifies LY2090314 as a potent inhibitor of\n                    <jats:italic>T. gondii<\/jats:italic>\n                    and\n                    <jats:italic>Cryptosporidium<\/jats:italic>\n                    growth in mammalian cells. Through a target deconvolution strategy combining forward genetics, transcriptome sequencing, and computational mutation analysis, we elucidate the parasiticidal mechanism of LY2090314 and demonstrate that\n                    <jats:italic>Tg<\/jats:italic>\n                    GSK3 kinase is its primary molecular target. We also report the first X-ray crystal structure of LY2090314 bound to\n                    <jats:italic>Tg<\/jats:italic>\n                    GSK3, resolved at 2.1\u2009\u00c5, which reveals an interaction mode characteristic of type I ATP-competitive inhibitors. Furthermore, interactome analysis uncovers functional connections between\n                    <jats:italic>Tg<\/jats:italic>\n                    GSK3 and key cytoskeletal and signaling regulators, providing insights into compound\u2019s effects. Collectively, these findings validate\n                    <jats:italic>Tg<\/jats:italic>\n                    GSK3 as a promising therapeutic target for toxoplasmosis and offer mechanistic insights into apicomplexan GSK3 biology.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-64701-7","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:12:38Z","timestamp":1762348358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural and functional characterization of TgGSK3, a druggable kinase in Toxoplasma gondii"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7546-1276","authenticated-orcid":false,"given":"Silvia","family":"Diaz-Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9739-7774","authenticated-orcid":false,"given":"Christopher","family":"Swale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0595-9563","authenticated-orcid":false,"given":"Irina","family":"Dobrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Wenker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1366-5856","authenticated-orcid":false,"given":"Marie-Pierre","family":"Brenier-Pinchart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alw\u00e9na","family":"Tollec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-6196","authenticated-orcid":false,"given":"Yohann","family":"Cout\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7733-6982","authenticated-orcid":false,"given":"Caroline","family":"Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-7952","authenticated-orcid":false,"given":"Fabrice","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-3351","authenticated-orcid":false,"given":"Matthew","family":"Bowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-8233","authenticated-orcid":false,"given":"Mohamed-Ali","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-0020","authenticated-orcid":false,"given":"Alexandre","family":"Bougdour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"64701_CR1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-018-0327-4","volume":"559","author":"M De Rycker","year":"2018","unstructured":"De Rycker, M., Baraga\u00f1a, B., Duce, S. L. & Gilbert, I. H. Challenges and recent progress in drug discovery for tropical diseases. Nature 559, 498\u2013506 (2018).","journal-title":"Nature"},{"key":"64701_CR2","unstructured":"World malaria report. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023 (2023)."},{"key":"64701_CR3","doi-asserted-by":"publisher","first-page":"e00054","DOI":"10.1016\/j.fawpar.2019.e00054","volume":"15","author":"O Djurkovi\u0107-Djakovi\u0107","year":"2019","unstructured":"Djurkovi\u0107-Djakovi\u0107, O., Dupouy-Camet, J., Van Der Giessen, J. & Dubey, J. P. Toxoplasmosis: overview from a One Health perspective. Food Waterborne Parasitol. 15, e00054 (2019).","journal-title":"Food Waterborne Parasitol."},{"key":"64701_CR4","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya, J. G. & Liesenfeld, O. Toxoplasmosis. Lancet 363, 1965\u20131976 (2004).","journal-title":"Lancet"},{"key":"64701_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0002-9394(14)73976-5","volume":"114","author":"PD Glasner","year":"1992","unstructured":"Glasner, P. D. et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am. J. Ophthalmol. 114, 136\u2013144 (1992).","journal-title":"Am. J. Ophthalmol."},{"key":"64701_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/00365540110080124","volume":"34","author":"P Bossi","year":"2002","unstructured":"Bossi, P. et al. Severe acute disseminated toxoplasmosis acquired by an immunocompetent patient in French Guiana. Scand. J. Infect. Dis. 34, 311\u2013314 (2002).","journal-title":"Scand. J. Infect. Dis."},{"key":"64701_CR7","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1128\/JCM.40.11.4037-4044.2002","volume":"40","author":"B Carme","year":"2002","unstructured":"Carme, B. et al. Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J. Clin. Microbiol. 40, 4037\u20134044 (2002).","journal-title":"J. Clin. Microbiol."},{"key":"64701_CR8","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1086\/521246","volume":"45","author":"M Demar","year":"2007","unstructured":"Demar, M. et al. Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin. Infect. Dis. 45, e88\u2013e95 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"64701_CR9","doi-asserted-by":"publisher","first-page":"E221","DOI":"10.1111\/j.1469-0691.2011.03648.x","volume":"18","author":"M Demar","year":"2012","unstructured":"Demar, M. et al. Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin. Microbiol. Infect. 18, E221\u2013E231 (2012).","journal-title":"Clin. Microbiol. Infect."},{"key":"64701_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2019.101509","volume":"35","author":"J Leroy","year":"2020","unstructured":"Leroy, J. et al. Severe toxoplasmosis imported from tropical Africa in immunocompetent patients: a case series. Travel Med. Infect. Dis. 35, 101509 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"64701_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pt.2017.10.010","volume":"34","author":"L Galal","year":"2018","unstructured":"Galal, L. et al. Toxoplasma and Africa: one parasite, two opposite population structures. Trends Parasitol. 34, 140\u2013154 (2018).","journal-title":"Trends Parasitol."},{"key":"64701_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3201\/eid1504.081306","volume":"15","author":"B Carme","year":"2009","unstructured":"Carme, B., Demar, M., Ajzenberg, D. & Dard\u00e9, M. L. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg. Infect. Dis. 15, 656\u2013658 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"64701_CR13","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1371\/journal.pntd.0000876","volume":"4","author":"A Mercier","year":"2010","unstructured":"Mercier, A. et al. Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. PLoS Negl. Trop. Dis. 4, e876 (2010).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"64701_CR14","doi-asserted-by":"publisher","first-page":"e00057","DOI":"10.1128\/CMR.00057-17","volume":"31","author":"IR Dunay","year":"2018","unstructured":"Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O. & Montoya, J. G. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin. Microbiol Rev. 31, e00057\u201317 (2018).","journal-title":"Clin. Microbiol Rev."},{"key":"64701_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10637-015-0278-7","volume":"33","author":"JE Gray","year":"2015","unstructured":"Gray, J. E. et al. A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin. Invest N. Drugs 33, 1187\u20131196 (2015).","journal-title":"Invest N. Drugs"},{"key":"64701_CR16","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3109\/10428194.2015.1122781","volume":"57","author":"DA Rizzieri","year":"2016","unstructured":"Rizzieri, D. A. et al. An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia. Leuk. Lymphoma 57, 1800\u20131806 (2016).","journal-title":"Leuk. Lymphoma"},{"key":"64701_CR17","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-15-2240","volume":"23","author":"A Walz","year":"2017","unstructured":"Walz, A. et al. Molecular pathways: revisiting glycogen synthase kinase-3\u03b2 as a target for the treatment of cancer. Clin. Cancer Res. 23, 1891\u20131897 (2017).","journal-title":"Clin. Cancer Res."},{"key":"64701_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn3231","volume":"14","author":"C Swale","year":"2022","unstructured":"Swale, C. et al. Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase. Sci. Transl. Med. 14, eabn3231 (2022).","journal-title":"Sci. Transl. Med."},{"key":"64701_CR19","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s44321-025-00252-0","volume":"17","author":"MG Robert","year":"2025","unstructured":"Robert, M. G. et al. Uncovering biomarkers for chronic toxoplasmosis detection highlights alternative pathways shaping parasite dormancy. EMBO Mol. Med 17, 1686\u20131715 (2025).","journal-title":"EMBO Mol. Med"},{"key":"64701_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-021-00959-9","volume":"19","author":"C Dard","year":"2021","unstructured":"Dard, C. et al. A brain cyst load-associated antigen is a Toxoplasma gondii biomarker for serodetection of persistent parasites and chronic infection. BMC Biol. 19, 25 (2021).","journal-title":"BMC Biol."},{"key":"64701_CR21","doi-asserted-by":"publisher","first-page":"792364","DOI":"10.3389\/fnmol.2021.792364","volume":"14","author":"SM Arciniegas Ruiz","year":"2022","unstructured":"Arciniegas Ruiz, S. M. & Eldar-Finkelman, H. Glycogen synthase kinase-3 inhibitors: preclinical and clinical focus on CNS-A Decade Onward. Front. Mol. Neurosci. 14, 792364 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"64701_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101871","volume":"23","author":"V Bellini","year":"2020","unstructured":"Bellini, V. et al. Target identification of an antimalarial oxaborole identifies AN13762 as an alternative chemotype for targeting CPSF3 in apicomplexan parasites. iScience 23, 101871 (2020).","journal-title":"iScience"},{"key":"64701_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.cell.2016.08.019","volume":"166","author":"SM Sidik","year":"2016","unstructured":"Sidik, S. M. et al. A genome-wide CRISPR Screen in toxoplasma identifies essential apicomplexan genes. Cell 166, 1423\u20131435 (2016).","journal-title":"Cell"},{"key":"64701_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50598","volume":"8","author":"A Hunt","year":"2019","unstructured":"Hunt, A. et al. Differential requirements for cyclase-associated protein (CAP) in actin-dependent processes of Toxoplasma gondii. eLife 8, e50598 (2019).","journal-title":"eLife"},{"key":"64701_CR25","doi-asserted-by":"publisher","first-page":"1010038","DOI":"10.3389\/fcimb.2022.1010038","volume":"12","author":"C Roum\u00e9gous","year":"2022","unstructured":"Roum\u00e9gous, C. et al. Identification of new components of the basal pole of Toxoplasma gondii provides novel insights into its molecular organization and functions. Front. Cell. Infect. Microbiol. 12, 1010038 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"64701_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13578-020-0376-x","volume":"10","author":"D Menolfi","year":"2020","unstructured":"Menolfi, D. & Zha, S. A. T. M. ATR and DNA-PKcs kinases\u2014the lessons from the mouse models: inhibition \u2260 deletion. Cell Biosci. 10, 8 (2020).","journal-title":"Cell Biosci."},{"key":"64701_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"64701_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tibs.2007.06.004","volume":"32","author":"AW Oliver","year":"2007","unstructured":"Oliver, A. W., Knapp, S. & Pearl, L. H. Activation segment exchange: a common mechanism of kinase autophosphorylation? Trends Biochem.Sci. 32, 351\u2013356 (2007).","journal-title":"Trends Biochem.Sci."},{"key":"64701_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abb6707","volume":"13","author":"DC Lim","year":"2020","unstructured":"Lim, D. C. et al. Redox priming promotes Aurora A activation during mitosis. Sci. Signal. 13, eabb6707 (2020).","journal-title":"Sci. Signal."},{"key":"64701_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.exppara.2009.07.005","volume":"124","author":"J-F Rossignol","year":"2010","unstructured":"Rossignol, J.-F. Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp. Parasitol. 124, 45\u201353 (2010).","journal-title":"Exp. Parasitol."},{"key":"64701_CR31","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.bbapap.2015.03.013","volume":"1854","author":"A Masch","year":"2015","unstructured":"Masch, A. & Kunick, C. Selective inhibitors of Plasmodium falciparum glycogen synthase-3 (PfGSK-3): new antimalarial agents? Biochim. et. Biophys. Acta (BBA) - Proteins Proteom. 1854, 1644\u20131649 (2015).","journal-title":"Biochim. et. Biophys. Acta (BBA) - Proteins Proteom."},{"key":"64701_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102360","volume":"298","author":"A Alder","year":"2022","unstructured":"Alder, A. et al. Functional inactivation of Plasmodium falciparum glycogen synthase kinase GSK3 modulates erythrocyte invasion and blocks gametocyte maturation. J. Biol. Chem. 298, 102360 (2022).","journal-title":"J. Biol. Chem."},{"key":"64701_CR33","doi-asserted-by":"publisher","first-page":"13172","DOI":"10.1021\/acs.jmedchem.2c00996","volume":"65","author":"KA Galal","year":"2022","unstructured":"Galal, K. A. et al. Identification of novel 2,4,5-trisubstituted pyrimidines as potent dual inhibitors of plasmodial Pf GSK3\/ Pf PK6 with activity against blood stage parasites in vitro. J. Med. Chem. 65, 13172\u201313197 (2022).","journal-title":"J. Med. Chem."},{"key":"64701_CR34","doi-asserted-by":"publisher","first-page":"104839","DOI":"10.1016\/j.bioorg.2021.104839","volume":"112","author":"C Moolman","year":"2021","unstructured":"Moolman, C., Van Der Sluis, R., Beteck, R. M. & Legoabe, L. J. Exploration of benzofuran-based compounds as potent and selective Plasmodium falciparum glycogen synthase kinase-3 (PfGSK-3) inhibitors. Bioorg. Chem. 112, 104839 (2021).","journal-title":"Bioorg. Chem."},{"key":"64701_CR35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1021\/jm301575n","volume":"56","author":"W Fugel","year":"2013","unstructured":"Fugel, W. et al. 3,6-Diamino-4-(2-halophenyl)-2-benzoylthieno[2,3- b]pyridine-5-carbonitriles are selective inhibitors of plasmodium falciparum glycogen synthase kinase-3. J. Med. Chem. 56, 264\u2013275 (2013).","journal-title":"J. Med. Chem."},{"key":"64701_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/cmi.12498","volume":"18","author":"A Curt-Varesano","year":"2016","unstructured":"Curt-Varesano, A., Braun, L., Ranquet, C., Hakimi, M.-A. & Bougdour, A. The aspartyl protease TgASP5 mediates the export of the Toxoplasma GRA16 and GRA24 effectors into host cells: TgASP5 is essential for GRA16 and GRA24 export. Cell. Microbiol. 18, 151\u2013167 (2016).","journal-title":"Cell. Microbiol."},{"key":"64701_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1128\/EC.00358-08","volume":"8","author":"M-H Huynh","year":"2009","unstructured":"Huynh, M.-H. & Carruthers, V. B. Tagging of endogenous genes in a toxoplasma gondii strain lacking Ku80. Eukaryot. Cell 8, 530\u2013539 (2009).","journal-title":"Eukaryot. Cell"},{"key":"64701_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.chom.2019.05.007","volume":"26","author":"G Wilke","year":"2019","unstructured":"Wilke, G. et al. A stem-cell-derived platform enables complete cryptosporidium development in vitro and genetic tractability. Cell Host Microbe 26, 123\u2013134.e8 (2019).","journal-title":"Cell Host Microbe"},{"key":"64701_CR39","doi-asserted-by":"publisher","unstructured":"Waldman, B. S. et al. Identification of a Master Regulator of Differentiation in Toxoplasma. Cell S0092867419313753 https:\/\/doi.org\/10.1016\/j.cell.2019.12.013.(2020).","DOI":"10.1016\/j.cell.2019.12.013"},{"key":"64701_CR40","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1107\/S1399004715011918","volume":"71","author":"O Svensson","year":"2015","unstructured":"Svensson, O., Malbet-Monaco, S., Popov, A., Nurizzo, D. & Bowler, M. W. Fully automatic characterization and data collection from crystals of biological macromolecules. Acta Crystallogr D. Biol. Crystallogr 71, 1757\u20131767 (2015).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"64701_CR41","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1107\/S1600577515016604","volume":"22","author":"MW Bowler","year":"2015","unstructured":"Bowler, M. W. et al. MASSIF-1: a beamline dedicated to the fully automatic characterization and data collection from crystals of biological macromolecules. J. Synchrotron Rad. 22, 1540\u20131547 (2015).","journal-title":"J. Synchrotron Rad."},{"key":"64701_CR42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1107\/S2059798318003728","volume":"74","author":"O Svensson","year":"2018","unstructured":"Svensson, O., Gilski, M., Nurizzo, D. & Bowler, M. W. Multi-position data collection and dynamic beam sizing: recent improvements to the automatic data-collection algorithms on MASSIF-1. Acta Crystallogr D. Struct. Biol. 74, 433\u2013440 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"64701_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr D. Biol. Crystallogr 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"64701_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl Crystallogr 40, 658\u2013674 (2007).","journal-title":"J. Appl Crystallogr"},{"key":"64701_CR45","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D. Biol. Crystallogr 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"64701_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1107\/S090744490705024X","volume":"64","author":"TC Terwilliger","year":"2008","unstructured":"Terwilliger, T. C. et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr D. Biol. Crystallogr 64, 61\u201369 (2008).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"64701_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S2052252514009324","volume":"1","author":"RP Joosten","year":"2014","unstructured":"Joosten, R. P., Long, F., Murshudov, G. N. & Perrakis, A. The PDB_REDO server for macromolecular structure model optimization. IUCrJ 1, 213\u2013220 (2014).","journal-title":"IUCrJ"},{"key":"64701_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0076-6879(95)55036-4","volume":"255","author":"AB Vojtek","year":"1995","unstructured":"Vojtek, A. B. & Hollenberg, S. M. Ras-Raf interaction: two-hybrid analysis. Methods Enzymol. 255, 331\u2013342 (1995).","journal-title":"Methods Enzymol."},{"key":"64701_CR49","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/nar\/25.10.2035","volume":"25","author":"F Beranger","year":"1997","unstructured":"Beranger, F. Getting more from the two-hybrid system: N-terminal fusions to LexA are efficient and sensitive baits for two-hybrid studies. Nucleic Acids Res. 25, 2035\u20132036 (1997).","journal-title":"Nucleic Acids Res."},{"key":"64701_CR50","doi-asserted-by":"crossref","unstructured":"Bartel, P., Chien, C.-T., Sternglanz, R. & Fields, S. Using the two-hybrid system to detect protein-protein interactions. in Cellular Interactions in Development: A Practical Approach (ed. Hartley, D. A.) 153\u2013179 (Oxford University Press). (1993).","DOI":"10.1093\/oso\/9780199633913.003.0007"},{"key":"64701_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ng0797-277","volume":"16","author":"M Fromont-Racine","year":"1997","unstructured":"Fromont-Racine, M., Rain, J. C. & Legrain, P. Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat. Genet 16, 277\u2013282 (1997).","journal-title":"Nat. Genet"},{"key":"64701_CR52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1101\/gr.2659105","volume":"15","author":"E Formstecher","year":"2005","unstructured":"Formstecher, E. et al. Protein interaction mapping: a Drosophila case study. Genome Res 15, 376\u2013384 (2005).","journal-title":"Genome Res"},{"key":"64701_CR53","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0022-2836(02)01009-4","volume":"323","author":"J Wojcik","year":"2002","unstructured":"Wojcik, J., Boneca, I. G. & Legrain, P. Prediction, assessment and validation of protein interaction maps in bacteria. J. Mol. Biol. 323, 763\u2013770 (2002).","journal-title":"J. Mol. Biol."},{"key":"64701_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/35051615","volume":"409","author":"J-C Rain","year":"2001","unstructured":"Rain, J.-C. et al. The protein\u2013protein interaction map of Helicobacter pylori. Nature 409, 211\u2013215 (2001).","journal-title":"Nature"},{"key":"64701_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47864","volume":"8","author":"A Mair","year":"2019","unstructured":"Mair, A., Xu, S.-L., Branon, T. C., Ting, A. Y. & Bergmann, D. C. Proximity labeling of protein complexes and cell-type-specific organellar proteomes in Arabidopsis enabled by TurboID. eLife 8, e47864 (2019).","journal-title":"eLife"},{"key":"64701_CR56","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1093\/bioinformatics\/btaa118","volume":"36","author":"D Bouyssi\u00e9","year":"2020","unstructured":"Bouyssi\u00e9, D. et al. Proline: an efficient and user-friendly software suite for large-scale proteomics. Bioinformatics 36, 3148\u20133155 (2020).","journal-title":"Bioinformatics"},{"key":"64701_CR57","doi-asserted-by":"publisher","first-page":"14898","DOI":"10.1021\/acs.analchem.0c00328","volume":"92","author":"Y Cout\u00e9","year":"2020","unstructured":"Cout\u00e9, Y., Bruley, C. & Burger, T. Beyond target\u2013decoy competition: stable validation of peptide and protein identifications in mass spectrometry-based discovery proteomics. Anal. Chem. 92, 14898\u201314906 (2020).","journal-title":"Anal. Chem."},{"key":"64701_CR58","doi-asserted-by":"publisher","first-page":"btac749","DOI":"10.1093\/bioinformatics\/btac749","volume":"39","author":"D Yu","year":"2023","unstructured":"Yu, D., Chojnowski, G., Rosenthal, M. & Kosinski, J. AlphaPulldown\u2014a python package for protein\u2013protein interaction screens using AlphaFold-Multimer. Bioinformatics 39, btac749 (2023).","journal-title":"Bioinformatics"},{"key":"64701_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-488","volume":"9","author":"T Hulsen","year":"2008","unstructured":"Hulsen, T., De Vlieg, J. & Alkema, W. BioVenn \u2013 a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9, 488 (2008).","journal-title":"BMC Genomics"},{"key":"64701_CR60","doi-asserted-by":"crossref","unstructured":"Mauri, M., Elli, T., Caviglia, G., Uboldi, G. & Azzi, M. RAWGraphs: A Visualisation Platform to Create Open Outputs. in Proceedings of the 12th Biannual Conference on Italian SIGCHI Chapter 1\u20135 (Association for Computing Machinery, 2017).","DOI":"10.1145\/3125571.3125585"},{"key":"64701_CR61","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkae268","volume":"52","author":"I Letunic","year":"2024","unstructured":"Letunic, I. & Bork, P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res 52, W78\u2013W82 (2024).","journal-title":"Nucleic Acids Res"},{"key":"64701_CR62","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"64701_CR63","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64701-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64701-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64701-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:07:43Z","timestamp":1762351663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64701-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64701"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64701-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"type":"electronic","value":"2041-1723"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9765"}}